Andrejs Koskevics @aksus1985: "📊 𝘽𝙞-𝙒𝙚𝙚𝙠𝙡𝙮 𝙋𝙤𝙧𝙩𝙛𝙤𝙡𝙞𝙤 𝙐𝙥𝙙𝙖𝙩𝙚: 𝙉𝙖𝙫𝙞𝙜𝙖𝙩𝙞𝙣𝙜..."

@aksus1985

Latvia

📊 𝘽𝙞-𝙒𝙚𝙚𝙠𝙡𝙮 𝙋𝙤𝙧𝙩𝙛𝙤𝙡𝙞𝙤 𝙐𝙥𝙙𝙖𝙩𝙚: 𝙉𝙖𝙫𝙞𝙜𝙖𝙩𝙞𝙣𝙜 𝙂𝙡𝙤𝙗𝙖𝙡 𝙑𝙤𝙡𝙖𝙩𝙞𝙡𝙞𝙩𝙮 Hello everyone! I’m combining the last two weeks into one comprehensive update. It has been a "perfect storm" in the markets, driven by significant escalations in the Middle East and shifting macro data. Despite the chaos, I am proud to report that our strategy is significantly outperforming the major indices. 📈 𝙋𝙚𝙧𝙛𝙤𝙧𝙢𝙖𝙣𝙘𝙚 𝙎𝙣𝙖𝙥𝙨𝙝𝙤𝙩 While the broad markets saw red over the last 30 days, our portfolio maintained strong upward momentum: 𝘼𝙨𝙨𝙚𝙩 / 𝙄𝙣𝙙𝙚𝙭 𝟭-𝙒𝙚𝙚𝙠 𝙍𝙚𝙩𝙪𝙧𝙣 𝟭-𝙈𝙤𝙣𝙩𝙝 𝙍𝙚𝙩𝙪𝙧𝙣 My Portfolio +7.02% +4.87% $SPX500 -2.04% -2.82% $NSDQ100 -1.27% -1.66% $EUSTX50 -6.28% -4.78% Key Takeaway: We are currently beating the S&P 500 by over 7% on a monthly basis. 🛡️ 𝙏𝙧𝙖𝙙𝙚 𝘼𝙣𝙖𝙡𝙮𝙨𝙞𝙨 The closure of the Strait of Hormuz and regional conflict sent shockwaves through energy and tech. Here is how I managed the volatility: The Winners ✅: Strong performance from $EC (Ecopetrol SA-ADR) and $USO (United States Oil Fund) capitalizing on the oil spike. $AMZN (Amazon.com Inc) also showed impressive resilience. The Lessons ⚠️: Positions in $NOVO-B.CO (Novo Nordisk B A/S) $TSM (Taiwan Semiconductor Manufacturing Co Ltd - ADR) and $CSG.NV (Czechoslovak Group) faced headwinds. My short on $SOXS ( Direxion Daily Semiconductor Bear 3X ETF) didn’t play out as expected due to the rapid shifts in semi-conductor sentiment. Current High-Conviction Holds: I am maintaining "Big Bets" on Tier-1 American giants: $NVDA (NVIDIA Corporation) , $MSFT (Microsoft) , $AMZN , and $AVGO (Broadcom Inc) I am also keeping a very close eye on $OIL prices. 🧠 𝙈𝙖𝙧𝙠𝙚𝙩 𝙊𝙪𝙩𝙡𝙤𝙤𝙠 & 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙮 I am currently cautiously optimistic but vigilant. Here is what is on my radar: Inflation & The FED: Expensive oil acts as a tax on the economy and fuels inflation. If energy stays high, the FED may be forced to keep rates higher for longer, which naturally slows equity growth. Labor Market: Last week’s unemployment data was concerning. We are watching for signs of a "hard landing." Risk Management: You may notice I am using leverage. I want to be clear: I only use leverage on top-tier, high-liquidity American companies to manage risk effectively. Growth Opportunities: I am still hunting for biotech "short squeeze" opportunities. However, with the current "fear" in the market, liquidity isn't flowing into speculative plays yet. We are waiting for the right entry point. 👥 𝘾𝙤𝙢𝙢𝙪𝙣𝙞𝙩𝙮 𝙂𝙧𝙤𝙬𝙩𝙝 Copiers: 22 (Average investment: 386$) Followers: 2,400+ (Up!)

Not investment advice. The author may have financial interests in the mentioned instruments.